Mesothelioma: all 475 studies

Page 5 of 5. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252
• Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural MesotheliomaActive, not recruitingNCT00715611Phase 2
• Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00703638Phase 1
• An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant MesotheliomaStatus unknownNCT00685204Phase 2
• A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant MesotheliomaWithdrawnNCT00668499Phase 1/2
• Dasatinib in Resectable Malignant Pleural MesotheliomaCompletedNCT00652574Phase 1
• Mesothelioma Avastin Plus Pemetrexed-cisplatin StudyCompletedNCT00651456Phase 2/3
• N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyTerminatedNCT00637624Not applicable
• Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaCompletedNCT00634205Phase 2
• Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentTerminatedNCT00585845Phase 1
• Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural MesotheliomaCompletedNCT00571298Phase 1
• A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaStatus unknownNCT00551252Phase 2
• Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural MesotheliomaCompletedNCT00535951Phase 1
• Bortezomib in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00513877Phase 2
• Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural MesotheliomaCompletedNCT00484276Phase 2
• Tomotherapy Treatment for MesotheliomaCompletedNCT00469196Phase 2
• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00458913Phase 2
• Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal CarcinomatosisStatus unknownNCT00454519Phase 2
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
• Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
• Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
• Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00334594Phase 2
• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
• Gene Therapy for Pleural MalignanciesCompletedNCT00299962Phase 1
• Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung CancerTerminatedNCT00281125Phase 1/2
• Dendritic Cell-based Immunotherapy in MesotheliomaCompletedNCT00280982Phase 1
• Study of Carboplatin and Vinorelbine in Malignant Pleural MesotheliomaCompletedNCT00272558Phase 2
• Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By SurgeryStatus unknownNCT00253409Not applicable
• Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00251550Phase 1/2
• Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00227630Phase 2
• A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNCT00190762Phase 3
• Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos WorkersCompletedNCT00188890
• Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural MesotheliomaCompletedNCT00165555Phase 1
• Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium ThiosulfateCompletedNCT00165516Phase 2
• Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated MesotheliomaCompletedNCT00137826Phase 2
• Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.CompletedNCT00107432Phase 2
• Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1
• Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00075699Phase 3
• Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsCompletedNCT00066404Phase 1
• Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
• Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCompletedNCT00061477Phase 2
• Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 2
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaCompletedNCT00053885Phase 2
• ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.Approved for marketingNCT00040625
• Erlotinib in Treating Patients With Malignant Mesothelioma of the LungCompletedNCT00039182Phase 2
• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
• Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the LungCompletedNCT00030745Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaStatus unknownNCT00030459Phase 2
• EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerTerminatedNCT00028782Not applicable
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaCompletedNCT00027703Phase 2
• Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaTerminatedNCT00027508Phase 2
• Gefitinib in Treating Patients With Malignant MesotheliomaCompletedNCT00025207Phase 2
• Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal CancerStatus unknownNCT00024271Phase 2
• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerCompletedNCT00024076Phase 2
• Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsCompletedNCT00020124Phase 1
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNCT00019825Phase 1
• Gemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaCompletedNCT00017186Phase 2
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant MesotheliomaCompletedNCT00006231Phase 3
• Vaccine Therapy and Ganciclovir in Treating Patients With MesotheliomaStatus unknownNCT00006216Phase 1
• SU5416 in Treating Patients With Malignant MesotheliomaCompletedNCT00006014Phase 2
• Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by SurgeryCompletedNCT00005636Phase 3
• Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the PleuraCompletedNCT00004920Phase 3
• Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedCompletedNCT00004254Phase 2
• Capecitabine in Treating Patients With Malignant MesotheliomaCompletedNCT00004183Phase 2
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II MesotheliomaCompletedNCT00003974Phase 1
• S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryCompletedNCT00003723Phase 2
• Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00003263Phase 1
• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy RegimenStatus unknownNCT00003034Phase 3
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerCompletedNCT00002475Phase 2
• High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or MesotheliomaStatus unknownNCT00002465Phase 1/2

← Mesothelioma overview